Please login to the form below
variant
This page shows the latest variant news and features for those working in and with pharma, biotech and healthcare.
New data from Moderna supports COVID boosters
The company also released new data from a real-world study following more than 350, 000 recipients of the vaccine that showed high levels of immunity to the delta variant. ... If vaccines are deployed where they would do the most good, they could hasten
Latest news
-
$47.5m research centre to seek genetic insights into disease
The centre will “generate systematic datasets” to help researchers around the world understand how human genetic variants affect risk for common yet complex diseases.
-
UK announces COVID boosters for a “bumpy winter” ahead
variants of the virus regardless of which COVID vaccine had been given for the first two doses.
-
Valneva shares fall as UK cancels COVID-19 vaccine order
Valneva has worked tirelessly, and to its best efforts, on the collaboration with HMG including investing significant resources and effort to respond to HMG’s requests for variant-derived vaccines,” said
-
Roche expands infectious disease test portfolio
MERS), the novel influenza virus (H1N1) swine, Ebola virus, Zika virus and most recently, the SARS-CoV-2 virus and its variants.
-
FDA opens door to COVID-19 booster jabs
The Centers for Disease Control recently announced that the Delta variant was the predominant strain of the virus in the country. ... ongoing studies to understand how long protection from the vaccines will last, also considering the spread of
$47.5m research centre to seek genetic insights into disease
UK announces COVID boosters for a “bumpy winter” ahead
Valneva shares fall as UK cancels COVID-19 vaccine order
Roche expands infectious disease test portfolio
FDA opens door to COVID-19 booster jabs
More from news
Approximately 14 fully matching, plus 189 partially matching documents found.
Latest Intelligence
-
Mastering oneself
Frequently, we have more information than we can easily process. System 1 heuristics offer to help us by focusing on the most recent or salient information – a variant of what Kahneman
-
Mastering oneself
Frequently, we have more information than we can easily process. System 1 heuristics offer to help us by focusing on the most recent or salient information – a variant of what Kahneman
-
Back to the future
I told them it would be speciation. Evolutionary forces like the six great shifts don’t change one entity into another, they cause it to divide into variants.
-
AI and accelerated computing ring in new era for healthcare
Its nanopore sequencing devices have been used in more than 50 countries to sequence and track new variants of the virus that causes COVID-19, as well as for large-scale ... Through deep learning, the base calling model is able to reach an overall
-
After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream
a cell type from thousands of potential variants.
Mastering oneself
Back to the future
AI and accelerated computing ring in new era for healthcare
After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest appointments
-
Galenica Group strengthens management team
We opted for these variant because of the excellent knowledge Stefan Schulze brings to further developing the business model of Vifor Pharma.”.
Galenica Group strengthens management team
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
#DemandDiversity: The science behind diversity
2) A 2018 analysis of studies looking for genetic variants associated with disease found that 78% of study participants were of European ancestry, compared with 10% of Asian ancestry and 2% ... from thousands of participants to find genetic variants
-
Blog - Vaccine Hesitant? It’s About What You Know and Who You Trust
the vaccines work, how safety is monitored, what new variants mean and, in the UK with at least 15m people having received at least one dose of a coronavirus vaccine (as
-
Travel in the time of COVID
6. Mutant variants are worrying the scientific community most at the moment.
-
What does the COVID-19 vaccine mean for the future of R&D?
The use of this technology should also be reassuring, should the current vaccines prove to be less effective against new COVID-19 variants, as these can be adapted rather than needing
-
A uniquely English genomic medicine service
As new knowledge is generated, we can identify rare variants,” says Tom.
#DemandDiversity: The science behind diversity
Blog - Vaccine Hesitant? It’s About What You Know and Who You Trust
Travel in the time of COVID
More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
CEO Pricing & Market Access, UK
-
Six figure salary
- Embattled Biogen talks up Aduhelm
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- David Hunt launches independent agency The Considered
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- EU “still interested” in Valneva COVID vaccine despite UK snub
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- New data from Moderna supports COVID boosters
- $47.5m research centre to seek genetic insights into disease
- Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards
- Nicky Hutchens appointed as deputy managing director at Four Health
- Health For All
- Digitalizing Muskuloskeletal Care to Improve Patient Outcomes and Reduce Cost
- Oxford PharmaGenesis wins Communiqué Medical Affairs Agency of the Year award at Communiqué 2021
- David Hunt launches independent agency The Considered
- EU “still interested” in Valneva COVID vaccine despite UK snub
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- Future of MHRA uncertain amid Brexit-fuelled shake up
- Lilly to target difficult-to-treat disease through tie-up with Lycia
PMHub
Havas Life Medicom
We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...
Latest intelligence
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
- Rare thoughts & outcomes - navigating pathways to better outcomes in rare
- ...
- How to pick the perfect training program for your healthcare professionals
- You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...
